Skip to content

SION SION Total Equity

Total Equity at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$19.36B+17.4%
AbbVie logo
AbbVieABBV
-$6.66B-569%
Septerna, Inc. logo
Septerna, Inc.SEPN
$378.46M+195%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$553.84M-22.6%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$926.1M-17.5%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$3.41B+34.4%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.8B
Enterprise value$1.74B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's total equity?
SION (SION) reported total equity of $288.21M in Q1 2026.
How has SION's total equity changed year-over-year?
SION's total equity decreased by 18.1% year-over-year, from $351.77M to $288.21M.
What is the long-term trend for SION's total equity?
Over 2 years (2023 to 2025), SION's total equity has grown at a 63.4% compound annual growth rate (CAGR), from -$114.88M to $306.83M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.